SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?

To: Dr. John M. de Castro who wrote (1491)10/20/1998 9:06:00 AM
From: Rudy Saucillo  Read Replies (2) | Respond to of 2742
 
Interesting. Galton and Naismith have clearly had a good working relationship during the course of the BlueStone contracts. Now that the second BlueStone contract has expired, this new agreement just allows the working relationship to continue with Naismith's new co. With the caveat that no terms were announced, I see this as something of a positive in that there's continuity in whatever discussions that are ongoing. Rudy



To: Dr. John M. de Castro who wrote (1491)10/20/1998 10:09:00 AM
From: Walter Morton  Respond to of 2742
 
I hope CIST is rewarding Naismith for the agreement that is to be announced within 11 days.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News